Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
Left atrial appendage occlusion and NOACs reduce mortality compared with warfarin in atrial fibrillation
LAAO, low-dose NOACs beat warfarin for atrial fibrillation survival
A network meta-analysis compared left atrial appendage occlusion (LAAO), low-dose NOACs, standard-dose NOACs, and warfarin in non-valvular a…
For people with atrial fibrillation, warfarin may be the worst option for survival. New analysis finds LAAO and NOACs outperform it.
Meta-analysis finds lower bleeding risk with apixaban and rivaroxaban vs VKAs in dialysis patients with AF
New Blood Thinners Cut Bleeding Risk For Dialysis Patients
This meta-analysis of observational studies and RCTs compared apixaban or rivaroxaban with vitamin K antagonists in dialysis patients with a…
New blood thinners could save lives for dialysis patients by cutting bleeding and stroke risks while waiting for bigger studies to confirm t…
DOACs versus VKAs for left ventricular thrombus management in adults
Newer Blood Thinners May Be Safer for Heart Clot Patients
A meta-analysis suggests DOACs may be a reasonable alternative to VKAs for left ventricular thrombus, with similar efficacy and potentially …
If you have a blood clot in your heart, newer blood thinners may be just as effective as warfarin with a lower risk of dangerous bleeding.
LAAC and DOACs match warfarin for stroke prevention in AF patients
LAAC and DOACs Cut Bleeding Risk Better Than Warfarin
A network meta-analysis of 78,594 AF patients found LAAC and DOACs offered similar protection against ischemic stroke as warfarin, while sig…
New research shows two new options for atrial fibrillation patients lower bleeding risks while keeping stroke protection the same as older d…
Proof of concept study uses preSCRIPT framework to annotate prescriptions in UK Biobank
preSCRIPT framework identifies genetic links to drug response in UK Biobank
This proof of concept study utilized the preSCRIPT framework to filter and annotate raw prescription data from the UK Biobank, which include…
A proof of concept study in the UK Biobank used preSCRIPT to find genetic links to how people respond to common medications like warfarin an…
Shorter fibrin clot lysis time linked to higher bleeding risk in atrial fibrillation patients on anticoagulants
Short clot breakdown time predicts higher bleeding risk
This RCT in 1,841 atrial fibrillation patients found that shorter pretreatment fibrin clot lysis time was associated with a significantly hi…
A simple blood test measuring how fast clots dissolve could help doctors spot patients at higher risk of bleeding before they even start tak…
Network meta-analysis compares prophylactic anticoagulants for central venous catheter-related thrombosis in cancer patients
Cancer Patients May Avoid Clots With Safer Blood Thinner
This network meta-analysis synthesizes data from 19 clinical studies regarding prophylactic anticoagulation in cancer patients with central …
A new analysis shows one specific blood thinner may protect cancer patients from dangerous clots with fewer side effects.
Narrative review examines left atrial appendage closure for stroke prevention in atrial fibrillation
The Tiny Ear-Shaped Pouch in Your Heart That Could Cause a Stroke
This narrative review evaluates left atrial appendage (LAA) closure as an alternative to warfarin, aspirin, or DOAC therapy for adults with …
A small heart implant seals off a stroke-risk pouch for atrial fibrillation patients who can't safely take blood thinners, with success rate…
Regular antithrombotic use associated with increased nonbiliary pancreatitis risk in UK Biobank cohort
Large UK study finds link between blood-thinning drugs and pancreatitis risk
A prospective cohort study of 431,754 UK Biobank participants found regular antithrombotic drug use was associated with a 31% increased risk…
Regular blood-thinning drug use is linked to a 31% higher risk of a specific pancreatitis type, with clopidogrel showing the strongest conne…
FDA Approves Xarelto (rivaroxaban) for multiple indications including stroke prevention in nonvalvular atrial fibrillation and treatment of VTE
FDA approves a new blood thinner called Xarelto for several heart and clot conditions
The FDA approved rivaroxaban (Xarelto), a factor Xa inhibitor, for multiple indications including reducing stroke risk in nonvalvular atrial…
FDA approves new blood thinner Xarelto to prevent dangerous clots in heart conditions, deep vein issues, and after major surgeries.